What Oral Anticoagulant Is Best After TAVR: Vitamin K Antagonists or Direct Oral Anticoagulants?
- PMID: 38355270
- DOI: 10.1016/j.jcin.2023.12.024
What Oral Anticoagulant Is Best After TAVR: Vitamin K Antagonists or Direct Oral Anticoagulants?
Keywords: DOAC; VKA; antithrombotic treatment; oral anticoagulation; transcatheter aortic valve replacement.
Conflict of interest statement
Funding Support and Author Disclosures Dr ten Berg has received institutional research grants from ZonMw (the Dutch government), AstraZeneca, Daiichi Sankyo, and Medtronic; and consultant fees/honoraria from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, Ferrer, Pfizer, and Celecor. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment on
-
Non-Vitamin K Antagonist Versus Vitamin K Antagonist Oral Anticoagulant Agents After Transcatheter Aortic Valve Replacement.JACC Cardiovasc Interv. 2024 Feb 12;17(3):405-418. doi: 10.1016/j.jcin.2023.11.038. JACC Cardiovasc Interv. 2024. PMID: 38355269
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
